Protalix BioTherapeutics, Inc. Quarterly Other Assets, Current in USD from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Protalix BioTherapeutics, Inc. quarterly Other Assets, Current history and growth rate from Q4 2013 to Q3 2024.
  • Protalix BioTherapeutics, Inc. Other Assets, Current for the quarter ending September 30, 2024 was $1.05M, a 6.67% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.05M -$75K -6.67% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $1.49M -$215K -12.6% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $812K +$54K +7.12% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $1.06M -$255K -19.5% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $1.13M -$611K -35.2% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $1.71M -$889K -34.2% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $758K -$365K -32.5% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $1.31M +$25K +1.95% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $1.74M -$538K -23.7% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $2.6M -$416K -13.8% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $1.12M -$631K -36% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $1.29M -$811K -38.7% Dec 31, 2021 10-K 2023-02-27
Q3 2021 $2.27M -$338K -12.9% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $3.01M +$120K +4.15% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $1.75M -$974K -35.7% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $2.1M +$264K +14.4% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $2.61M -$144K -5.23% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $2.89M +$645K +28.7% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $2.73M +$1.02M +59.9% Mar 31, 2020 10-Q 2020-06-01
Q4 2019 $1.83M -$45K -2.4% Dec 31, 2019 10-K 2021-03-30
Q3 2019 $2.76M +$137K +5.23% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $2.25M -$251K -10% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $1.71M -$888K -34.2% Mar 31, 2019 10-Q 2019-05-06
Q4 2018 $1.88M -$57K -2.95% Dec 31, 2018 10-K 2020-03-12
Q3 2018 $2.62M -$70K -2.6% Sep 30, 2018 10-Q/A 2019-03-18
Q2 2018 $2.5M -$1.58M -38.8% Jun 30, 2018 10-Q/A 2019-03-18
Q1 2018 $2.59M -$890K -25.5% Mar 31, 2018 10-Q/A 2019-03-18
Q4 2017 $1.93M -$714K -27% Dec 31, 2017 10-K 2019-03-18
Q3 2017 $2.69M +$1.64M +157% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $4.08M -$1.05M -20.5% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $3.48M +$539K +18.3% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $2.65M +$981K +58.8% Dec 31, 2016 10-K 2018-03-06
Q3 2016 $1.05M -$1.67M -61.5% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $5.14M +$2.81M +121% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $2.95M +$14K +0.48% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $1.67M -$535K -24.3% Dec 31, 2015 10-K 2017-03-16
Q3 2015 $2.72M Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $2.33M Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $2.93M Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $2.2M +$745K +51.1% Dec 31, 2014 10-K 2016-03-08
Q4 2013 $1.46M Dec 31, 2013 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.